Clinical trials for breast cancer and informed consent: How women helped make research a cooperative venture

The Voice of Breast Cancer in Medicine and Bioethics

Volumn , Issue , 2006, Pages 133-161

  Kopelman, Loretta M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859871428     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-4477-1_10     Document Type: Chapter

References (65)

1. Almy, T.P. 1977. Therapeutic trials, town and gown, and the public interest. New England Journal of Medicine 296: 279-280.
2. Angell, M. 1984. Patient preferences in randomized clinical trials. New England Journal of Medicine 310, no. 21: 1385-1387.
3. Beauchamp, T.L. 1980. Commentary: The ambiguities of deferred consent. IRB 2, no. 7: 6-8.
4. Beauchamp, T.L., et al. 1991. Ethical guidelines for epidemiologists. Journal of Clinical Epidemiology, 44S, no.1: 151S-169S.
5. Beecher, H.K. 1966. Ethics and clinical research. New England Journal of Medicine 274: 1354-1360.
6. Bonchek, L.I. 1979. Are randomized trials appropriate for evaluating new operations? New England Journal of Medicine 301: 44-45.
7. Buchanan, A.E. and D.W. Brock. 1989. Deciding for Others: The Ethics of Surrogate Decision Making. Cambridge, MA: Cambridge University Press. Canterbury v. Spence. 464 F.2d 722 (D.C. Cir. 1972).
8. Check, W.A. 1980. Protecting and informing research subjects. Journal of the American Medical Association 243: 1985-1993.
9. Curran, W.J. 1979. Reasonableness and randomization in clinical trials: Fundamental law and governmental regulations. New England Journal of Medicine 300: 1273-1275.
10. DeVita, V.T., Jr. 1978. The evolution of therapeutic research in cancer. New England Journal of Medicine 298: 907-910.
11. Ellenberg, S.S. 1984. Randomized designs in comparative clinical trials. New England Journal of Medicine 310: 1404-1408.
12. Faden, R.R., T.L. Beauchamp, and N.M.P. King. 1986. History and Theory of Informed Consent. New York: Oxford University Press.
13. Fisher, B. 1980. The national surgical adjuvant project for breast and bowel cancer. (NSABP Protocol B-06). Distributed in 1980 to surgeons.
14. Fisher, B., J.-H. Jeong, S. Anderson, et al. 2002. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. New England Journal of Medicine 347, no. 8: 567-575.
15. Fisher, B., M. Bauer, R. Margolese, et al. 1985. Five-year result of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. New England Journal of Medicine 312: 665-673.
16. Fletcher, R.H. and S.W. Fletcher. 1979. Clinical research in medical journals. New England Journal of Medicine 301: 180-183.
17. Fost, N. 1979. Consent as a barrier to research. New England Journal of Medicine 300: 1272-1279.
18. Fost, N. and J. Robertson. 1980. Deferring consent with incompetent patients in an intensive care unit. IRB 2, no. 7: 5-6.
19. Freedman, B. 1987. Equipoise and the ethics of clinical research. New England Journal of Medicine 317, no. 3: 141-145.
20. Fried, C. 1974. Medical Experimentation: Personal Integrity and Social Policy. New York: American Elsevier Publishing Company.
21. Gert, B., C.M. Culver, and K.D. Clouser. 1997. Bioethics: A Return to Fundamentals. New York: Oxford University Press.
22. Gordon, Jr., R.S. 1978. Clinical trials. New England Journal of Medicine 298: 400-401.
23. Gore, S.M. 1981. Assessing clinical trials-first steps. British Medical Journal 282: 1605-1607.
24. Harris, J.R., S. Hellman, and D.W. Kinne. 1985. Limited surgery and radiotherapy for early breast cancer. New England Journal of Medicine 313: 1365-1368.
25. Hill, A.B. 1963. Medical ethics and controlled trials. British Medical Journal 1: 1043-1049.
26. Jonas, H. 1969. Philosophical reflections on experimenting with human subjects. Daedalus 98, no. 2: 219-247.
27. Katz, J. 1984. Why doctors don't disclose uncertainty. Hastings Center Report (February): 35-44.
28. A1972. Experimentation With Human Beings, Part III. New York: Russell Sage Foundation.
29. Kopelman, L.M. 2004. Research methodology/II. Clinical trials. In Encyclopedia of Bioethics, 3rd Edition, ed. Stephen G. Post, 2334-2343. New York: MacMillan Reference USA.
30. A2004b. Research policy/II. Risk and vulnerable groups. In Encyclopedia of Bioethics, 3rd Edition, ed. Stephen G. Post, 2365-2372. New York: MacMillan Reference USA.
31. A1990. On the evaluative nature of competency and capacity judgments. International Journal of Law and Psychiatry 13, no. 4 (Fall): 309-329.
32. A1986. Consent on randomized clinical trials: Are there moral or design problems? The Journal of Medicine and Philosophy 11: 317-345.
33. A1983. Randomized clinical trials, consent and the therapeutic relationship. Clinical Research 31, no. 1: 1-11.
34. A1981. Estimating risk in human research. Clinical Research 29: 1-8.
35. Lerner, B.H. 2001. The Breast Cancer Wars: Hope, Fear, and the Pursuit of a Cure in Twentieth -Century America. New York: Oxford University Press.
36. Levine, R.J. 1981. Ethics and Regulation of Clinical Research, 1st Edition. Baltimore: Urban and Schwarzenberg Publishing Company.
37. McCartney, J.J. 1979. A response to Dr. Whitley. Hastings Center Report 9, no. 4: 46-47.
38. A1978. Encephalitis and ara-A: An ethical case study. Hastings Center Report 8, no. 6: 5-7.
39. McNeil, B.J., R. Weichselbaum, and S.G. Pauker. 1978. Fallacy of the five year survival in lung cancer. New England Journal of Medicine 299: 1397-1401.
40. Mead, M. 1969. Research with human beings: A model derived from anthropological field research. In Experimentation with Human Subjects, ed. P.A. Freund, 152-177. New York: George Braziller Company.
41. Mill, J.S. 1974. On Liberty. New York: Penguin Books.
42. Miller, L.J. 1980. Informed consent I. Journal of American Medical Association 244, no. 18: 2100-2103.
43. Moeschberger, M.L., et al. 1985. Methods of randomization in controlled clinical trials. American Journal of Emergency Medicine 3, no. 5: 467-473.
44. National Commission for the Protection of Human Subjects. 1979. The Belmont Report, 1979. Report to the Secretary of the Department of Health, Education, and Welfare. (Now the Department of Health and Human Values). Washington, D.C.
45. Nuremberg Code. Germany (Territory under Allied Occupation, 1945-1955: U.S. Zone) Military Tribunals. 1947. Permissible medical experiments. In Trials of War Criminals Before the Nuremberg Tribunals Under Control Law No. 10. Vol. 2. Washington, D.C.: U.S. Government Printing Office. Available at: Http://ohrp.osophs.dhhs.gov/irb/irb-Appendices.htm.
46. President's Commission for the Study of Ethical Problems and Biomedical and Behavioral Research. 1983. Implementing Human Research Regulations. Washington, D.C.
47. President's Commission for the Study of Ethical Problems and Biomedical and Behavioral Research. 1982. Making Health Care Decisions, Vol. 1 and Vol. 2. Washington, D.C.
48. Ramsey, P. 1970. The Patient as Person. New Haven, CT: Yale University Press.
49. Rutstein, D.D. 1969. The ethical design of human experiments. Daedalus 98, no. 2: 523-541.
50. Schaffner, K.F. 2004. Research methodology/I. Conceptual issues. In Encyclopedia of Bioethics, 3rd Edition, ed. Stephen G. Post, 2326-2334. New York: MacMillan Reference USA.
51. Taylor, K.M., R.G. Margolese, and C.L. Soskolne. 1984. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. New England Journal of Medicine 310, no. 21: 1363-1367.
52. Urbach, P. 1982. Randomization and the designs of experimentations. Philosophy of Science 52: 256-273.
53. U.S. Code of Federal Regulations (CFR) 1981. Public welfare final regulations amending basic HHS policy for the protection of subjects. Title 45 CFR 46. Federal Register 46, no. 16: 8366-8392.
54. Vaisrub, N. 1985. Manuscript review from a statistician's viewpoint. Journal of American Medical Association 253, no. 21: 3145-3147.
55. Van Eys, J. 1979. Randomized clinical trials in pediatric oncology. New England Journal of Medicine 300: 1115.
56. Veatch, R. 1982. The patient as partner: Ethics in clinical oncology research. The Johns Hopkins Medical Journal 151: 155-161.
57. Wei, L.J., and S. Durham. 1978. The randomized play-The-winner rule in medical trials. Journal of the American Statistical Association 73: 834-840.
58. Weinstein, M.C. 1974. Allocation of subjects in medical experiments. New England Journal of Medicine 291: 1278-1286.
59. Wexler, N.S., et al. 1985. Huntington's disease homozygotes identified. Abstract. American Journal of Human Genetics 37, no. 4 (July Supplement): A82.
60. Whitley, R.J. 1979. Encephalitis and adenine arabinoside: An indictment without facts. Hastings Center Report 9(4), no. 4: 44-46.
61. Wickler, D. 1981. The ethics of clinical trials. Seminars in Oncology 8, no. 4: 437-441.
62. Wolfe, J.E. and R.C. Bone. 1977. Informed consent in critical care medicine. Clinical Research 25: 53-56.
63. World Medical Association, Declaration of Helsinki. 1964. Recommendations guiding medical doctors and biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland. (Amended in 1975, 1983, 1989, 1996, and 2001).
64. Zelen, M. 1979. A new design for randomized clinical trials. New England Journal of Medicine 300: 1242-1245.
65. A1969. Play the winners role and the controlled clinical trials. Journal of the American Statistical Association 64: 131-146.